Login / Signup

Uterine changes in transgender men receiving testosterone therapy.

Eliane Dias da SilvaRaquel Camara RiveriPoli Mara SpritzerTayane Muniz Fighera
Published in: European journal of endocrinology (2024)
In the present study, GAHT induced an atrophic condition of the endometrium in two-thirds of the transgender men, with a limited AR expression in the endometrial region. The present results suggest that testosterone based GAHT for a mean of 5 years is safe in transgender men achieving amenorrhea.
Keyphrases
  • hiv testing
  • middle aged
  • replacement therapy
  • poor prognosis
  • men who have sex with men
  • high glucose
  • diabetic rats
  • oxidative stress
  • bone marrow
  • endothelial cells